Pfizer Inc. Earnings

Pfizer Inc.’s revenue fell -7.82% since last year same period to $13715Mn in the Q1 2025. On a quarterly growth basis, Pfizer Inc. has generated -22.79% fall in its revenue since last 3-months.

Pfizer Inc.’s net profit fell -4.75% since last year same period to $2967Mn in the Q1 2025. On a quarterly growth basis, Pfizer Inc. has generated 623.66% jump in its net profits since last 3-months.

Pfizer Inc.’s net profit margin jumped 3.33% since last year same period to 21.63% in the Q1 2025. On a quarterly growth basis, Pfizer Inc. has generated 837.25% jump in its net profit margins since last 3-months.

Pfizer Inc.’s price-to-earnings ratio after this Q1 2025 earnings stands at 17.37.

Pfizer Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.66 - a 40.43% jump from last quarter’s estimates.

Pfizer Inc.’s earning per share (EPS) estimates for the current year stand at 0.66.

Pfizer Inc.’s earning per share (EPS) jumped 12.2% since last year same period to 0.92 in the Q1 2025. This indicates that the Pfizer Inc. has generated 12.2% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Pfizer Inc.’s return on assets (ROA) stands at 0.05.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Pfizer Inc.’s return on equity (ROE) stands at 0.09.

Pfizer Inc. declared 0.43 dividend per share during the earnings announcement for Q1 2025.